Clinical Trial

Small Extracellular Vesicles and Insulin Action

Study acronym: SEV
Recruiting
View on ClinicalTrials.gov →
Summary
The goals of this research study are to: 1) understand why some people with obesity are protected from developing conditions such as type 2 diabetes and cardiovascular disease while others are more likely to develop obesity-related conditions; 2) assess the effect of small extracellular vesicles (sEVs also called exosomes), obtained from human participants, on metabolic function in cultured cells and in mice.
Protocol Amendment History 2 changes
notable Primary completion moved earlier: 2029-01-01 -> 2028-06-01 2026-07-17
minor Completion moved earlier: 2029-09-01 -> 2028-08-31 2026-07-17
Trial Details
NCT Number NCT05933707
Lead Sponsor Washington University School of Medicine
Conditions Obesity, Insulin Resistance, Metabolically Healthy Obesity, Obesity, Metabolically Benign
Enrollment 72 participants
Start Date 2023-06-14
Primary Completion 2028-06-01 (estimated)
Study Completion 2028-08-31 (estimated)
Updated on ClinicalTrials.gov 2026-07-17